FTC alleges no actual harm, Qualcomm says

The Federal Trade Commission’s suit against Qualcomm for its patent licensing practices does not allege a plausible antitrust theory, the technology company asserted this week in its motion to dismiss, echoing statements made by the agency’s acting head Maureen Ohlhausen.